drugset / Trial / NCT05153785

Perioperative Intravenous Lidocaine in Liver Surgery

NCT05153785

Phase 2/3 Completed 124 enrolled Lund University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized double blinded placebo-controlled study, conducted in Lund, Sweden. Patients will be randomized in two groups, with a ratio of 1:1. The experimental arm will receive intravenous Lidocaine perioperatively, and the Control arm will receive placebo, i.e. normal Saline. Postoperative both arms will get routine pain Control with PCA, Patient Controlled Analgesia with an intravenous Oxycodone-infusion. Outcome-measures will include patients pain intensity scoring, and opioid consumption.

Timeline

Start
2021-11-15
Primary completion
2025-06-12
Completion
2025-12-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous